Dynamic Technology Lab’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,017
Closed -$267K 1392
2024
Q4
$267K Buy
+47,017
New +$303K 0.04% 683
2022
Q3
Sell
-14,814
Closed -$88K 1560
2022
Q2
$88K Buy
+14,814
New +$100K 0.01% 1001
2020
Q2
Sell
-38,324
Closed -$351K 1378
2020
Q1
$351K Buy
+38,324
New +$440K 0.07% 519
2019
Q3
Sell
-12,860
Closed -$350K 1330
2019
Q2
$350K Buy
+12,860
New +$294K 0.06% 572
2018
Q3
Sell
-10,576
Closed -$207K 1368
2018
Q2
$207K Sell
10,576
-4,677
-31% -$92.4K 0.03% 837
2018
Q1
$287K Buy
15,253
+4,096
+37% +$88.5K 0.04% 728
2017
Q4
$185K Buy
+11,157
New +$191K 0.03% 887

Other funds holding VYGR

Dynamic Technology Lab's VYGR Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 47,017 shares — an estimated $267K sold.

Dynamic Technology Lab first reported a position in VYGR in Q4 2017 and held it in 7 quarters. The position peaked at $351K in Q1 2020. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 47,017 Voyager Therapeutics shares in Q1 2025, an estimated $267K.
  • Dynamic Technology Lab first reported a position in Voyager Therapeutics in Q4 2017 and held it in 7 quarters.
  • Dynamic Technology Lab's Voyager Therapeutics position peaked at $351K in Q1 2020.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.